Kaita, Kelly D.

Publishing since 1997 (Senior)

Has published 13 publications in 13 years

Number of publications published per year by Kaita, Kelly D.. (Source : PubMed)

Distribution of publications types for Kaita, Kelly D.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Patel K, Benhamou Y, Yoshida EM, Kaita KD, Zeuzem S, Torbenson M, Pulkstenis E, Subramanian GM, McHutchison JG. An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C.  J. Viral Hepat.  2009;16;3  
•  Bain VG, Kaita KD, Marotta P, Yoshida EM, Swain MG, Bailey RJ, Patel K, Cronin PW, Pulkstenis E, McHutchison JG, Subramanian GM. Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patients.  Clin. Gastroenterol. Hepatol.  2008;6;6  
•  Bain VG, Yoshida EM, Kaita KD, Swain MG, Heathcote EJ, Garcia A, Moore PA, Yu R, McHutchison JG, Subramanian GM. Dynamics of interferon-specific gene expression in peripheral blood of interferon alfa-naïve patients with genotype 1 chronic hepatitis C infection treated with albumin-interferon alfa.  Hepatol. Res.  2006;35;4  
•  Bain VG, Kaita KD, Yoshida EM, Swain MG, Heathcote EJ, Neumann AU, Fiscella M, Yu R, Osborn BL, Cronin PW, Freimuth WW, McHutchison JG, Subramanian GM. A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients.  J. Hepatol.  2006;44;4  
•  Minuk GY, Gutkin A, Wong SG, Kaita KD. Patient concerns regarding chronic hepatitis C infections.  J. Viral Hepat.  2005;12;1  
•  Kojima H, Kaita KD, Zhang M, Giulivi A, Minuk GY. Genomic analysis of a recently identified virus (SEN virus) and genotypes D and H by polymerase chain reaction.  Antiviral Res.  2003;60;1  
•  Kojima H, Kaita KD, Xu Z, Ou JH, Gong Y, Zhang M, Minuk GY. The absence of up-regulation of telomerase activity during regeneration after partial hepatectomy in hepatitis B virus X gene transgenic mice.  J. Hepatol.  2003;39;2  
•  Moses S, Mestery K, Kaita KD, Minuk GY. Viral hepatitis in a Canadian street-involved population.  Can J Public Health  2002;93;2  
•  Minuk GY, Weinstein S, Kaita KD. Serum cholesterol and low-density lipoprotein cholesterol levels as predictors of response to interferon therapy for chronic hepatitis C.  Ann. Intern. Med.  2000;132;9  
•  Minuk GY, Uhanova J, Kaita KD. The prevalence of intrinsic host risk factors associated with progressive disease in patients with chronic hepatitis C viral infections.  Can J Public Health  2000;91;3  

[ See timeline ] [ See all publications ]